Physician profile
Michael Janice
NPI 1417363268
$12,115.52
in general payments reported to CMS, 2019-2025
13 companies · $93.27 in 2025
The $93.27 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,448 · 2020: $5,529 · 2021: $1,387 · 2022: $2,040 · 2023: $1,472 · 2024: $146 · 2025: $93.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,029 · Food and Beverage: $682.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,029.11 |
| Food and Beverage | $682.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,026.41 | 2019-2022 | |
| Davol INC. | $2,587.60 | 2022-2025 | Phasix Mesh |
| Becton, Dickinson and Company | $174.79 | 2023 | Phasix Mesh |
| Astrazeneca Pharmaceuticals Lp | $74.00 | 2020 | |
| Medtronic, INC. | $50.92 | 2025 | Catalyft Pl Expandable Interbody System |
| Zyla Life Sciences, INC. | $45.28 | 2020 | |
| Integra Lifesciences Corporation | $40.30 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Acell, INC. | $34.61 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $18.74 | 2020 | |
| Innocoll Pharmaceuticals Limited | $17.14 | 2021 | |
| Olympus America INC. | $16.65 | 2019 | |
| Merit Medical Systems INC | $15.90 | 2021 | |
| Smith+Nephew, INC. | $13.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Janice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.